Actively Recruiting
Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy
Led by Cairo University · Updated on 2024-11-01
60
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will be carried out on 60 patients both gender male and female with diabetic neuropathy with age55-65 years. The patients will be selected from Elmahmoudia hospital .patients will be randomly assigned to two groups.
CONDITIONS
Official Title
Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 55 and 65 years
- Diagnosis of diabetes based on World Health Organization criteria
- Body Mass Index greater than 25 kg/m2
- Clinically diagnosed with diabetic neuropathy
- Taking oral hypoglycemic drugs with controlled diabetes mellitus
- Willing to follow study procedures and interventions
- Able to provide informed consent
- Presenting with Distal Symmetric Polyneuropathy (DSPN) with a score of 7 or more on the Michigan Neuropathy Screening Instrument (MNSI) questionnaire
- Moderately controlled blood pressure
You will not qualify if you...
- Other significant neurological or musculoskeletal disorders that could affect results
- Severe cognitive impairment or inability to provide informed consent
- Recent surgeries or major medical events affecting outcomes
- Bone fractures
- Heart failure
- Uncooperative behavior
- Anemia
- Liver diseases
- Smoking
- Presence of cardiac pacemaker, automatic implantable cardioverter defibrillator (AICD), or other implanted electrical devices
- Existing deep vein thrombosis (DVT)
- Metal implants
- Current foot ulceration or other lower limb skin ulcers
- Any other cause of neuropathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Physical Therapy
Dokki, Egypt
Actively Recruiting
Research Team
A
alaa marzouk, master
CONTACT
M
marwa mahmoud, phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here